Hims Hers Really Growth Stock Faces Reality Check Now
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
New guidance on supplement timing says the best time take your vitamins depends on vitamin type and possible interact...
OpenAI CEO Sam Altman acknowledges AI is shifting the traditional labor-capital balance, highlighting job fears as au...
Snowflake stock price prediction signals a pivotal path forward as AI-native cloud initiatives expand and profitabili...
As hybrid work remains the norm in 2026, a first-hand look at the best things i’ve bought reveals durable, affordable...
Rising tensions around Iran push energy costs higher and complicate the macro outlook. Analysts warn that stagflation...
Two new lawsuits filed by Anthropic target the Department of Defense, arguing for stricter controls on how its Claude...
As AI stocks cool, a rotation toward durable, revenue-generating assets accelerates. A new wheel technology startup i...
Markets tilt away from AI hype toward real-world assets as the Great Rotation accelerates. TerraTread debuts a durabl...
Oil prices edge higher around $99 a barrel on March 12, 2026, as markets assess supply constraints and demand trends....
Microsoft rolls out Copilot Health, a new module inside Copilot that links wearables, electronic health records, and ...
UK tax authorities plan to buy crypto forensic tools to pursue digital asset tax fraud. The move signals a broader pu...